Abstract: The topical use of 5,6,7-trihydroxyheptanoic acid and analogs alone or in combination with histamine antagonists and/or mast cell stabilizers is disclosed for the treatment of ocular allergy.
Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
Type:
Grant
Filed:
February 7, 2007
Date of Patent:
July 12, 2011
Assignee:
Novartis AG
Inventors:
Onkar N. Singh, G. Michael Wall, Rajni Jani, Masood A. Chowhan, Wesley Wehsin Han
Abstract: 1,4-disubstituted-1,2,3-triazole UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.
Abstract: Methods for treating an allergic or inflammatory disease or other Syk-mediated disease or Syk-mediated condition characterized by administering a composition which contains a therapeutically effective amount of a 3,6-substituted imidazol[1,2-b]pyridazine compound.
Type:
Grant
Filed:
March 10, 2010
Date of Patent:
March 15, 2011
Assignee:
Alcon, Inc.
Inventors:
Mark R. Hellberg, Steven T. Miller, Andrew Rusinko
Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials comprise di-block or tri-block macromers containing hydrophilic side-chains. The materials have improved glistening resistance.
Abstract: Disclosed are soft, high refractive index, methacrylic device materials. The materials contain an ethoxylate monomer to reduce glistenings and a long-chain alkyl methacrylate monomer for softening.
Abstract: Disclosed are soft, high refractive index, acrylic device materials having improved strength. The materials contain a phenylene-siloxane macromer.
Type:
Grant
Filed:
April 29, 2008
Date of Patent:
December 7, 2010
Assignee:
Alcon, Inc.
Inventors:
Douglas C. Schlueter, David L. Jinkerson
Abstract: Methods for treating an allergic or inflammatory disease or other Syk-mediated disease or Syk-mediated condition characterized by administering a composition which contains a therapeutically effective amount of a 5-substituted 2-aminopyridine compound.
Type:
Grant
Filed:
January 12, 2006
Date of Patent:
September 21, 2010
Assignee:
Alcon, Inc.
Inventors:
Mark R. Hellberg, Steven T. Miller, Andrew Rusinko
Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials comprise di-block or tri-block macromers containing a hydrophilic block in the polymer backbone. The materials have improved glistening resistance.
Abstract: Methods of making 1-alkylindazoles are described. The methods involve reacting a 2-alkylaminobenzonitrile with a nitrosating agent followed by reduction-cyclization of the resulting nitrosamine to form a 1-alkyl-3-aminoindazole. The 1-alkyl-3-aminoindazole can be deaminated to form a 1-alkylindazole which ultimately can be used to form desired indazoles which are preferably pharmaceutically active products. The process of the present invention further permits the formation of enantiomerically enriched or pure indazoles such as aminoalkyl indazoles.
Type:
Grant
Filed:
February 10, 2009
Date of Patent:
September 21, 2010
Assignee:
Alcon, Inc.
Inventors:
Pete Delgado, Raymond E. Conrow, W. Dennis Dean
Abstract: High refractive index copolymers suitable for use in ophthalmic devices are disclosed. The copolymers comprise a single aryl hydrophobic monomer as a device forming monomer. In addition, the copolymers comprise a non-polymerizable block copolymer surfactant. The copolymers have a reduced tendency to form glistenings when stored in water at physiological temperatures.
Abstract: High refractive index copolymers suitable for use in ophthalmic devices are disclosed. The copolymers comprise two or more aryl hydrophobic monomers and a non-polymerizable propylene oxide-ethylene oxide-propylene oxide block copolymer surfactant having a molecular weight of approximately 3600 and approximately 40% ethylene oxide units by weight. The copolymers have a reduced tendency to form glistenings when stored in water at physiological temperatures compared to similar copolymers lacking the non-polymerizable surfactant.
Abstract: Chromophores that absorb both UV and short wavelength visible light are disclosed. The chromophores are particularly suitable for use in intraocular lens materials.
Type:
Grant
Filed:
August 7, 2008
Date of Patent:
August 24, 2010
Assignee:
Alcon, Inc.
Inventors:
Joseph I. Weinschenk, III, Douglas C. Schlueter, David L. Jinkerson